On 2025-05-14, Zentalis Pharmaceuticals, Inc. (ZNTL) announced earnings per share of $-0.67 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.67.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-0.56 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.67 | $-0.67 |
| 2025-03-26 | 2024-12-31 | $-0.75 | $-0.66 |
| 2024-11-12 | 2024-09-30 | $-0.92 | $-0.56 |
| 2024-08-09 | 2024-06-30 | $-0.83 | $-1.24 |
| 2024-05-07 | 2024-03-31 | $-0.85 | $0.14 |
| 2024-02-27 | 2023-12-31 | $-0.92 | $-0.83 |
| 2023-11-06 | 2023-09-30 | $-1.01 | $-0.79 |
| 2023-08-09 | 2023-06-30 | $-1.06 | $-1.85 |
| 2023-05-10 | 2023-03-31 | $-0.96 | $-1.07 |
| 2023-03-01 | 2022-12-31 | $-1.09 | $-0.92 |
| 2022-11-09 | 2022-09-30 | $-1.15 | $-0.96 |
| 2022-08-09 | 2022-06-30 | $-1.21 | $-1.34 |
| 2022-05-05 | 2022-03-31 | $-1.20 | $-1.31 |
| 2022-02-24 | 2021-12-31 | $-1.34 | $-1.11 |
| 2021-11-10 | 2021-09-30 | $-1.31 | $-0.09 |
| 2021-08-12 | 2021-06-30 | $-1.14 | $-1.34 |
| 2021-05-17 | 2021-03-31 | $-0.96 | $-1.24 |
| 2021-03-25 | 2020-12-31 | $-0.97 | $-1.01 |
| 2020-11-09 | 2020-09-30 | $-0.73 | $-0.91 |
| 2020-08-13 | 2020-06-30 | $-0.50 | $-0.78 |
| 2020-05-15 | 2020-03-31 | $-0.70 | $-2.88 |